Skip to content
10-K

Annual Report

bluebird bio, Inc.

0001293971-25-000009

← back to feed
Filed
Mar 27, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 25, 2025 9.79M sh
Shares Diluted FY 2024 · Dec 31, 2024 9.69M sh
Shares Diluted restated FY 2024 · Dec 31, 2023 5.49M sh
Capex FY 2024 · Dec 31, 2024 $2.6M
Capex FY 2024 · Dec 31, 2023 $4.19M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$260.02M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$235.05M
Short Term Debt FY 2024 · Dec 31, 2024 $71.51M
Short Term Debt FY 2024 · Dec 31, 2023 $0
Cash And Equivalents FY 2024 · Dec 31, 2024 $62.31M
Cash And Equivalents FY 2024 · Dec 31, 2023 $221.76M
Stockholders Equity FY 2024 · Dec 31, 2024 −$31.53M
Stockholders Equity FY 2024 · Dec 31, 2023 $194.54M
Stockholders Equity restated FY 2024 · Dec 31, 2022 $134.33M
Current Liabilities FY 2024 · Dec 31, 2024 $321.46M
Current Liabilities FY 2024 · Dec 31, 2023 $200.11M
Total Liabilities FY 2024 · Dec 31, 2024 $491.77M
Total Liabilities FY 2024 · Dec 31, 2023 $424.62M
Current Assets FY 2024 · Dec 31, 2024 $154.67M
Current Assets FY 2024 · Dec 31, 2023 $281.69M
Total Assets FY 2024 · Dec 31, 2024 $460.23M
Total Assets FY 2024 · Dec 31, 2023 $619.16M
Eps Diluted FY 2024 · Dec 31, 2024 −$24.84
Eps Diluted restated FY 2024 · Dec 31, 2023 −$38.59
Eps Basic FY 2024 · Dec 31, 2024 −$24.84
Eps Basic restated FY 2024 · Dec 31, 2023 −$38.59
Sga Expense FY 2024 · Dec 31, 2024 $167.87M
Sga Expense FY 2024 · Dec 31, 2023 $165.51M
Rd Expense FY 2024 · Dec 31, 2024 $94.25M
Rd Expense FY 2024 · Dec 31, 2023 $167.65M
Net Income FY 2024 · Dec 31, 2024 −$240.72M
Net Income FY 2024 · Dec 31, 2023 −$211.91M
Operating Income FY 2024 · Dec 31, 2024 −$270.46M
Operating Income FY 2024 · Dec 31, 2023 −$244.26M
Gross Profit FY 2024 · Dec 31, 2024 −$5.57M
Gross Profit FY 2024 · Dec 31, 2023 −$4.03M
Cost Of Revenue FY 2024 · Dec 31, 2024 $89.38M
Cost Of Revenue FY 2024 · Dec 31, 2023 $33.53M
Revenue FY 2024 · Dec 31, 2024 $83.8M
Revenue FY 2024 · Dec 31, 2023 $29.07M